Abstract

Background and Aims : Carbamylation is a post-translational protein modification increased in CKD patients as well as in late-stage atherosclerotic plaques in patients without CKD. Carbamylation was shown to cause pro-atherogenic alteration in plasma proteins and was significantly associated with increased mortality in CKD patients. However, the exact mechanisms and role of protein carbamylation in atherogenesis are not known.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call